Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Thursday 23 April 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

Sales & Marketing

user scolling on smart phone

Sponsored

Solution Spotlight: Own The Moments That Matter Most

Medscape Contextual Moments is a suite of integrated opportunities that deliver messaging alongside independent Medscape trusted editorial content.

R&D

HCP takes blood pressure of pregnant woman

DiaMedica’s novel biologic basal dilator: Bringing hope to p...

pharmaphorum spoke with DiaMedica’s CEO, Rick Pauls, about the company's efforts in preeclampsia, early-onset preeclampsia, and ischaemic stroke.

Digital

Hallucination of an AI concept

Controlling AI hallucinations: Building evidence-based trust...

When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.

Market Access

pharmaphorum podcast episode 110

How manufacturing keeps pace with innovation in cell and gen...

Cell and gene therapies are one of the most fast-moving and paradigm-shifting areas in pharmaceutical development today, bringing curative treatments to patients for the first time for cert

Digital

GenAi healthcare discovery graphic

Trust and treatment: GenAI in life sciences in 2024

In 2023, the life sciences industry was rocked by generative artificial intelligence. This year, we'll see some of these ideas become reality.

Sales & Marketing

Mehrnaz Campbell

The Omni Advantage: A concise roadmap for change, for the pe...

The book launch for pharma industry veteran and award-winning businesswoman Merhnaz Campbell’s The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales E

Load more results

Sales & Marketing

Sales & Marketing

user scolling on smart phone

Sponsored

Solution Spotlight: Own The Moments That Matter Most

Medscape Contextual Moments is a suite of integrated opportunities that deliver messaging alongside independent Medscape trusted editorial content.

Sales & Marketing

Man listening to audio

Sponsored

Pushing through barriers to commercial launch success, with ...

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

Digital

Digital

Hallucination of an AI concept

Controlling AI hallucinations: Building evidence-based trust...

When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.

Digital

Diverse hires

Changing Faces: Digital and supplier, March 2026

Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.

Market Access

Market Access

Biotech capital concept

Capital discipline in biotech: Building enduring companies w...

Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.

Market Access

Metrics discussion around boardroom table

Highlights from the UK’s December 2025 VPAG metrics

Leela Barham looked at the latest metrics used to monitor the UK’s voluntary pricing scheme.

Editor's Picks

Lilly says Foundayo safety confirmed in ACHIEVE-4 trial

Trump names Erica Schwartz to fill leadership void at CDC

OpenAI introduces GPT-Rosalind, its drug discovery AI

Amazon launches its AI drug discovery platform

Revolution rockets on strong pancreatic cancer data

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Precision medicine, DNA on target

From promise to practice: What must happen next for genetic ...

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

Oncology

Interview at LSX 2026 with Roi Raz

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Oncology

Oncologists assessing a brain scan

From preclinical toxicology to clinical safety: The path for...

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

Patients

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

Patients

Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

R&D

R&D

HCP takes blood pressure of pregnant woman

DiaMedica’s novel biologic basal dilator: Bringing hope to p...

pharmaphorum spoke with DiaMedica’s CEO, Rick Pauls, about the company's efforts in preeclampsia, early-onset preeclampsia, and ischaemic stroke.

R&D

12 Questions with Faruk Uzman

Sponsored

12 Questions with Faruk Uzman

Find out more about Faruk Uzman, VP EMEA at Boston Scientific, in a new 12 Questions With.

R&D

Strait of Hormuz

The conflict in the Middle East is exposing dangerous prepar...

If the conflict persists, the risk of widespread medicine shortages becomes increasingly real.

Editor's Picks

Lilly says Foundayo safety confirmed in ACHIEVE-4 trial

Trump names Erica Schwartz to fill leadership void at CDC

OpenAI introduces GPT-Rosalind, its drug discovery AI

Amazon launches its AI drug discovery platform

Revolution rockets on strong pancreatic cancer data

News

MSD cuts $1bn AI tool deal with Google Cloud

MSD cuts $1bn AI tool deal with Google Cloud

MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees worldwide.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights further

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company